Sling Therapeutics
Ann Arbor
About Sling Therapeutics
Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $35.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: slingtx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/sling-therapeutics-95384 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.